SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib

Malignant melanoma is the most aggressive skin cancer and can only be cured if detected early. Unfortunately, later stages of the disease do not guarantee success due to the rapid rate of melanoma cell metastasis and their high resistance to applied therapies. The search for new molecular targets an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Karwaciak, Iwona, Sałkowska, Anna, Karaś, Kaja, Sobalska-Kwapis, Marta, Walczak-Drzewiecka, Aurelia, Pułaski, Łukasz, Strapagiel, Dominik, Dastych, Jarosław, Ratajewski, Marcin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562913/
https://ncbi.nlm.nih.gov/pubmed/31091806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050673
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller